OTC: NRDE

Stark Novus Financial Inc.

CIK 0001759546 · Consumer Discretionary · SIC 3711 · Motor Vehicles & Passenger Car Bodies

Micro Revenue $2M Assets $44M as of Aug 1, 2026

Each report below shows a 3-bullet preview. Free accounts read 3 full reports a month — narrative summary, section diffs, and EDGAR-cited quotes.

Sign up free

Want to see a complete report first? Today's free report (AAPL 10-Q) is open in full — no account needed.

8-K Filed Jul 21, 2026 · Period ending Jul 15, 2026

Summary not yet generated.

8-K Filed Jun 30, 2026 · Period ending Jun 26, 2026

Summary not yet generated.

Partner

Trade NRDE commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Jun 4, 2026 · Period ending Jun 2, 2026

Summary not yet generated.

10-Q Filed May 15, 2026 · Period ending Mar 31, 2026

Summary not yet generated.

10-K/A Filed Apr 29, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

10-K Filed Mar 26, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

10-Q Filed Nov 13, 2025 · Period ending Sep 30, 2025

Summary not yet generated.

10-K Filed Mar 28, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

424B5 Filed Nov 7, 2022

Summary not yet generated.

424B3 Filed Aug 31, 2022

Summary not yet generated.

424B3 Filed Aug 19, 2022

Summary not yet generated.

424B3 Filed Aug 19, 2022

Summary not yet generated.

S-1 Filed Jul 30, 2021

Summary not yet generated.

S-1/A Filed Dec 1, 2020

Summary not yet generated.

S-1 Filed Nov 12, 2020

Summary not yet generated.

424B4 Filed Feb 28, 2019

Summary not yet generated.

S-1/A Filed Feb 26, 2019

Summary not yet generated.

S-1/A Filed Feb 21, 2019

Summary not yet generated.

S-1 Filed Jan 18, 2019

Summary not yet generated.

Latest financial statements

From 10-Q filed May 15, 2026 (period ending Mar 31, 2026). SEC XBRL (companyfacts) — not generated by the model.

SEC XBRL

Consolidated Statements of Operations (Unaudited)

Description Q1 ended Mar 31, 2026 Q3 ended Sep 30, 2025
Operating expenses:
Selling, general and administrative 1.5 1.2
Total operating expenses 0.7 (0.4)
Operating income (0.7) 0.4
Other income/(expense), net (0.02) (0.02)
Income before income taxes (0.1) 1.0
Net income (0.1) 1.0
Basic earnings per share (0.05) 0.01
Diluted earnings per share (0.05) 0.01

Consolidated Balance Sheets (Unaudited)

Description Mar 31, 2026 Dec 31, 2025
Current assets:
Cash and equivalents 25.1 34.4
Short-term investments 7.3 4.7
Prepaid expenses and other current assets 0.2 0.2
Other current assets 2.9 5.4
Total current assets 35.4 44.8
Deferred income taxes and other assets 8.8 2.2
TOTAL ASSETS 44.2 47.0
Current liabilities:
Accounts payable 0.09 0.5
Other current liabilities 0.5 0.5
Total current liabilities 0.6 1.0
Other long-term liabilities 2.6 5.0
Total liabilities 3.2 6.0
Shareholders' equity:
Capital in excess of stated value 1,181 1,182
Accumulated other comprehensive income (loss) (0.4) (0.4)
Retained earnings (deficit) (1,179) (1,179)
Total shareholders' equity 1.9 2.6
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY 44.2 47.0

Consolidated Statements of Cash Flows (Unaudited)

Description Q1 ended Mar 31, 2026 Nine months ended Sep 30, 2025
Operating Activities:
Net cash from operating activities (2.6) (5.6)
Investing Activities:
Net cash from investing activities (6.7) 0.8
Financing Activities:
Net increase/(decrease) in cash (9.3) (4.9)

Amounts in millions USD; EPS as reported. Line labels are presentation-friendly mappings of filer XBRL tags — not a re-audit of the full statements. Use EDGAR for interactive notes and detail. Interactive statements & notes on EDGAR ↗